Proviron (Mesterolone)

DHT Derivative | Mood, Libido & Muscle Hardening

Weight: 304.47 Da

Half-life: ~12 hours

5 studies

2011 latest

Well Studied

Dose 25-75 mg/day

Frequency 1-3x per day (oral)

Cycle 8-12 weeks (or ongoing with TRT)

Storage Room temperature (68-77F). Protect from moisture and light.

Accumulation Plotter

Community Research

Join others researching Proviron — share findings, ask questions, and learn from real experiences

View Results Aggregated community findings

Discussion Questions & experiences

Submit Your Findings Contribute your research data

Proviron (mesterolone) is an orally active dihydrotestosterone (DHT) derivative that has been used in clinical medicine since the 1960s, primarily in Europe and other international markets. Unlike most oral anabolic steroids, Proviron is not 17-alpha alkylated, which gives it a remarkably low hepatotoxicity profile. It was originally developed for the treatment of androgen deficiency, male infertility (at low doses it can improve sperm quality without fully suppressing the HPT axis), and mood disturbances related to low androgen status. Proviron is approved in numerous countries outside the United States including Germany, the UK, and several countries across Asia, South America, and the Middle East. Its most distinctive pharmacological property is its exceptionally strong binding affinity for sex hormone-binding globulin (SHBG), which effectively displaces testosterone from SHBG and increases the proportion of circulating free testosterone. This mechanism makes Proviron a popular adjunct to testosterone replacement therapy and performance enhancement protocols, where it amplifies the biological activity of co-administered testosterone without meaningfully increasing total androgen load. Proviron is also valued for its anti-estrogenic properties — as a DHT derivative, it cannot aromatize to estrogen, and it competes with testosterone for the aromatase enzyme, reducing overall estrogen conversion. Users consistently report improvements in mood, libido, confidence, and a general sense of well-being, along with a harder, drier, and more defined physical appearance.

Mechanism of Action

Proviron exerts its effects primarily through direct binding to the androgen receptor (AR) as a potent DHT analogue. However, its most therapeutically relevant mechanism is its exceptionally high binding affinity for sex hormone-binding globulin (SHBG). By occupying SHBG binding sites, Proviron displaces testosterone that would otherwise be bound and biologically inactive, effectively increasing free testosterone levels without requiring additional exogenous testosterone. This SHBG-displacement mechanism is the primary reason Proviron is considered synergistic with testosterone — it amplifies the effective androgenic signal from a given dose of testosterone. Proviron also acts as a mild aromatase inhibitor. Because it is a DHT derivative, it cannot be converted to estrogen by the aromatase enzyme, and it competes with aromatizable androgens (like testosterone) for access to aromatase, reducing the overall rate of estrogen conversion. This dual mechanism — increasing free testosterone while reducing estrogen — produces the characteristic effects of improved mood, enhanced libido, and the harder, drier physique that Proviron is known for. In muscle tissue, Proviron's anabolic effects are limited because it is rapidly inactivated by 3-alpha hydroxysteroid dehydrogenase, similar to DHT itself. This enzyme is highly expressed in skeletal muscle, which is why Proviron is not considered a significant muscle-building agent on its own but rather an enhancer of other androgens.

01 Strong SHBG binding frees more circulating testosterone, enhancing TRT efficacy

02 Improved mood, motivation, confidence, and overall sense of well-being

03 Significant enhancement of libido and sexual function

04 Anti-estrogenic effect reduces the need for dedicated aromatase inhibitors

05 Harder, drier, more defined physical appearance without water retention

06 Minimal hepatotoxicity due to absence of 17-alpha alkylation

07 May improve sperm quality at low doses in subfertile men

08 Rapid onset of subjective well-being effects (often within days)

Molecular Data

Molecular Weight

304.47 Da

Type

DHT derivative (C20H32O2)

Peak 0.0 mcg

Trough 0.0 mcg

SS Peak 0.0 mcg

SS Trough 0.0 mcg

Research Indications

Sexual Health

Libido Enhancement most effective

Proviron is one of the most reliable compounds for improving sexual desire and drive. Its DHT activity directly stimulates libido pathways, while its SHBG-binding effect increases free testosterone availability. Effects are often noticeable within the first week of use.

Erectile Quality effective

By increasing free testosterone and DHT activity, Proviron can improve erectile firmness and frequency. Particularly effective in men whose erectile issues are related to low free testosterone or elevated SHBG.

Male Infertility (Low-Dose) moderate

At doses of 25-50 mg/day, Proviron has been used clinically to improve sperm count and motility in oligospermic men. At these low doses, HPT axis suppression is minimal. Higher doses may suppress spermatogenesis.

Neurological / Mood

Mood and Well-Being effective

Proviron is widely reported to produce a noticeable improvement in mood, confidence, and overall psychological well-being. This is attributed to increased free testosterone and direct androgenic activity in the central nervous system. Many users describe a calm, confident, and motivated mindset.

Androgen Deficiency-Related Depression moderate

In men with documented androgen deficiency, Proviron has been used to alleviate depressive symptoms, fatigue, and loss of motivation. Not a replacement for standard psychiatric treatment but can complement hormonal optimization.

Body Composition

Muscle Hardening and Definition effective

Proviron reduces water retention and gives a visibly harder, more defined appearance. It does not significantly build muscle mass on its own due to rapid inactivation in muscle tissue, but it enhances the aesthetic quality of existing musculature.

Free Testosterone Optimization effective

By binding SHBG and freeing bound testosterone, Proviron effectively increases the anabolic signal from a given testosterone dose. This makes it a potent adjunct to any testosterone-based protocol for improving body composition outcomes.

Endocrine / Hormonal

SHBG Reduction most effective

Proviron has one of the highest binding affinities for SHBG of any androgen. This displaces testosterone from SHBG, increasing free testosterone without increasing total testosterone dose. Particularly useful in men with elevated SHBG who present with low free testosterone despite adequate total testosterone levels.

Mild Estrogen Control moderate

Proviron provides a mild anti-estrogenic effect through aromatase competition, which can reduce or eliminate the need for a dedicated aromatase inhibitor on moderate testosterone doses. It is not a replacement for an AI in heavily aromatizing protocols but can meaningfully reduce estrogen-related side effects in standard TRT.

Dosing Protocols

Proviron is administered exclusively as an oral tablet, typically available in 25 mg tablets. Unlike most oral anabolic steroids, Proviron is not 17-alpha alkylated and instead relies on its 1-methyl DHT structure for oral bioavailability. This makes it one of the safest oral androgens with respect to liver toxicity. The 12-hour half-life supports once or twice daily dosing for stable blood levels.

Goal	Dose	Frequency	Route
Low Dose - Libido and Mood Support	25 mg/day	Once daily	Oral
Standard - TRT Adjunct	50 mg/day	25 mg twice daily (morning and evening)	Oral
Higher Dose - Enhanced Protocol	75 mg/day	25 mg three times daily	Oral

Interactions

Testosterone

Proviron's primary value as a stack component lies in its strong SHBG binding, which displaces testosterone and increases the proportion of biologically active free testosterone. This amplifies the effects of a given testosterone dose without requiring an increase in the dose itself. Proviron also reduces estrogen conversion through aromatase competition, meaning less AI may be needed. The combination reliably enhances mood, libido, and physical hardening beyond what testosterone alone provides.

synergistic

Anastrozole

Proviron's mild anti-estrogenic effect through aromatase competition can reduce the required dose of anastrozole or other aromatase inhibitors. In many men on standard TRT doses, adding Proviron at 50 mg/day eliminates the need for an AI entirely. When both are used, monitor estradiol to avoid over-suppression, which impairs lipids, joint health, bone density, and libido.

compatible

Finasteride

Finasteride blocks the conversion of testosterone to DHT via 5-alpha reductase inhibition. Proviron is a DHT derivative whose effects depend on direct androgenic receptor activation as a DHT analogue. While finasteride does not directly deactivate Proviron, the combination is pharmacologically contradictory — one compound is a DHT agonist and the other suppresses DHT production. Concurrent use undermines the rationale for using either compound and may produce unpredictable androgenic signaling.

avoid

What to Expect

Day 1-3

Onset of subjective well-being effects. Many users report improved mood, confidence, and mental clarity within the first few days. Increased libido may become noticeable. Proviron's rapid oral absorption and 12-hour half-life mean steady-state levels are approached quickly.

Week 1-2

Full libido and mood effects are typically established. Noticeable increase in sexual desire, morning erections, and overall drive. If stacking with testosterone, the SHBG-displacement effect begins to amplify free testosterone levels. Mild anti-estrogenic effects may start reducing water retention.

Week 2-4

Visible changes in physical appearance begin. Reduced subcutaneous water retention gives a harder, drier look. Improved muscle definition and vascularity, particularly in leaner individuals. Mood and well-being effects continue to strengthen and stabilize.

Week 4-8

Full aesthetic and hormonal effects realized. Maximum SHBG displacement and free testosterone optimization. The combination of increased free testosterone, reduced water retention, and direct androgenic activity produces the characteristic hardened, defined appearance. Libido and mood benefits are well-established.

Week 8+

Sustained benefits with ongoing use. Monitor DHT-related side effects (hair, prostate) with long-term use. Lipid panels should be checked periodically as Proviron can mildly suppress HDL cholesterol over time. Many users run Proviron continuously alongside TRT with good tolerability.

Side Effects & Safety

Common Side Effects

Accelerated hair thinning or loss in those predisposed to male pattern baldness (DHT-mediated)
Mild suppression of endogenous testosterone at higher doses (though less suppressive than most AAS)
Oily skin and increased sebum production
Mild HDL cholesterol suppression with extended use
Increased body hair growth

Stop Signs - Discontinue if:

Difficulty urinating or significant changes in urinary flow (prostate concern)
Prolonged erection lasting more than 4 hours (priapism — seek emergency care)
Yellowing of skin or eyes (jaundice — though extremely unlikely with non-alkylated Proviron)
Severe or persistent headaches
Chest pain or significant cardiovascular symptoms

Contraindications

Prostate cancer (active or history of androgen-sensitive prostate cancer)
Severe liver impairment (though hepatotoxicity risk is minimal)
Breast cancer in males
Hypersensitivity to mesterolone or any excipients
Women who are pregnant or may become pregnant (androgenic effects on fetus)

Quality Checklist

Good Signs

Pharmaceutical-grade tablets from licensed manufacturer (Bayer Proviron is the most recognized brand)
Tablets are clearly scored, uniformly sized, and properly sealed in blister packs
Proper labeling with manufacturer, lot number, expiration date, and 25 mg dosage marking
Purchased from a licensed pharmacy with valid prescription (where legally available)

Warning Signs

Underground lab (UGL) tablets without pharmaceutical verification
Tablets that crumble easily, are irregularly sized, or have inconsistent coloring
Products claiming higher-than-standard doses (50 mg+ per tablet) from unknown manufacturers

Bad Signs

No labeling, missing lot numbers, or absent expiration dates
Packaging with spelling errors, low-quality printing, or counterfeit brand markings
Tablets with unusual taste, smell, or appearance inconsistent with known pharmaceutical product
Product sourced without any testing or third-party verification

References

Mesterolone treatment of patients with pathological spermiogram: Effect on sperm count, motility, and morphology

Matalka, K.Z., Issa, R.A., Al-Saleh, A.

Clinical and Experimental Obstetrics and Gynecology (2001)

Demonstrated that mesterolone (Proviron) at 75 mg/day for 12 weeks significantly improved sperm count and motility in subfertile men, supporting its clinical use in male infertility treatment.
Effect of mesterolone on serum FSH, LH and plasma testosterone in normal adult men

Bals-Pratsch, M., Knuth, U.A., Nieschlag, E.

Acta Endocrinologica (1986)

Characterized the endocrine effects of mesterolone in healthy men, showing dose-dependent suppression of gonadotropins (FSH and LH) with minimal impact on total testosterone at low doses, confirming Proviron's relatively mild suppressive profile compared to other androgens.
The role of dihydrotestosterone in benign prostatic hyperplasia

Bartsch, G., Rittmaster, R.S., Klocker, H.

European Urology (2000)

Review of DHT's role in prostate physiology and pathology, providing context for the prostate-related considerations of DHT derivatives including mesterolone. Established the mechanistic basis for monitoring prostate health during DHT-analogue therapy.
Sex hormone-binding globulin: origin, function and clinical significance

Hammond, G.L.

Annals of Clinical Biochemistry (2011)

Comprehensive review of SHBG biology, including how androgens like mesterolone with high SHBG binding affinity can displace testosterone and modulate free testosterone levels. Provides the mechanistic foundation for Proviron's role as a free testosterone enhancer.
Pharmacology of testosterone replacement therapy preparations

Nieschlag, E., Behre, H.M.

Andrology: Male Reproductive Health and Dysfunction (Springer) (2010)

Textbook review covering the pharmacology of mesterolone among other androgen preparations. Notes its unique non-17-alpha-alkylated oral structure, favorable hepatic safety profile, and established clinical role in Europe for androgen deficiency and infertility.

Disclaimer

This information is for educational and research purposes only. Consult a healthcare professional before use.